Novartis

East Hanover, New Jersey 07963

4 studies enrolling now · 82 studies all time

What they study most

Acute Lymphoblastic Leukemia, Advanced Non-small Cell Lung Cancer and MET Exon 14 Skipping Mutation, Allergic Asthma, Amyotrophic Lateral Sclerosis, Anaphylaxis, Anemia, Aplastic, Aplastic Anemia, Atherosclerotic Cardiovascular Disease, BRAF Positive Metastatic Melanoma, BRAF-positive Metastatic Melanoma, Breast Cancer, Cardiovascular Disease

Studies at this site

• A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan — Recruiting now
• A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
• A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients — Recruiting now
• A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients — Recruiting now
• A Study of Treatment Patterns and Annualized Relapse Rate in Multiple Sclerosis Patients Who Escalate Versus Continue Disease-Modifying Therapies Following Relapse — Completed
• A Real-World Study of Early Breast Cancer Patients Eligible for Treatment With CDK4/6 Inhibitors — Completed
• A Real-world Study Comparing the Effectiveness of Ofatumumab and Ocrelizumab Treatment in Multiple Sclerosis Patients — Completed
• A Study of Real-World Treatment Patterns and Outcomes Among HR+/HER2- Metastatic Breast Cancer Patients Treated With First-Line CDK4/6 Inhibitors — Completed
• A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients — Completed
• A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617 — Completed
• A Study of the Safety and Effectiveness of Eltrombopag in Combination With Immunosuppressive Therapy (IST) in Korean Pediatric Patients With Treatment Naïve Severe Aplastic Anemia — Completed
• A Study to Assess the Real-World Effectiveness of Inclisiran and PCSK9 mAbs in Chinese Hypercholesterolemia Adult Patients — Completed
• A Real-world Study of Disease-modifying Therapy Treatment Outcomes in Patients With Spinal Muscular Atrophy — Completed
• A Real-world Study to Compare the Effectiveness of Sacubitril/Valsartan Versus ACEi/ARB in HFrEF Patients — Completed
• Treatment Patterns and Key Endpoints Among Patients With Chronic-Phase Chronic Myeloid Leukemia in a Community Oncology Setting — Completed
• A Study of Dosing Patterns and Costs in Patients With Spinal Muscular Atrophy Receiving Disease Modifying Therapies — Completed
• A Real-world Study of Indian Patients With Advanced Breast Cancer Treated With Ribociclib — Completed
• A Study to Evaluate the Demographics and Treatment Patterns of Myelofibrosis Patients Treated With Ruxolitinib in Turkey — Completed
• Treatment Landscape and Real-World Dosing Patterns With CDK4/6 Inhibitors for Breast Cancer in Portugal — Completed
• A Study of the Epidemiology and Hospital Management of Patients With PROS in France — Completed
• A Study of Accelerated Guideline-Directed Medical Therapy for Heart Failure — Completed
• Potential Eligibility and Estimated Preventable Cardiovascular Disease Events From Inclisiran Treatment in the United States — Completed
• Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia (CML) in All Lines of Treatment — Completed
• A Real-world Study About the Impact of Siponimod Treatment on Secondary Progressive Multiple Sclerosis Patients in Russia — Completed
• A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia Patients — Completed
• A Study of Real-world Treatment and Burden of Chronic Myeloid Leukemia Patients in Japan — Completed
• A Study of Real-world Outcomes Among Patients Treated With Ribociclib — Completed
• A Study to Evaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma — Completed
• A Study of Real-World Outcomes of Ribociclib in First-Line Treatment for Metastatic HR+/HER2- Breast Cancer — Completed
• A Real-world Study of the Effectiveness of Tisagenlecleucel in Acute Lymphoblastic Leukemia Patients — Completed
• A Study About the Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis — Completed
• Patterns of Inclisiran Use in the Real World: An Analysis of US Databases — Completed
• Real-world Outcomes of Aplastic Anemia Patients Treated With Eltrombopag: A Medical Claims Database Study — Completed
• A Study to Describe a Group of Spanish Patients With FMF and to Identify Suboptimally Treated Patients With Minimal Disease Activity and Its Impact on Quality of Life — Completed
• A Study of Multiple Sclerosis Routine Clinical Practice: Impact on Adherence and Clinical Outcomes of Ofatumumab Treated Patients — Completed
• Effectiveness of Ofatumumab in Real-world Practice — Completed
• A Canadian Study of Persistence on Ofatumumab Using Patient Support Program Data — Completed
• Real World Effectiveness, Persistence, Tolerability, and Safety of Ofatumumab in Clinical Practice — Completed
• A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in Brazil — Stopped early
• A Real-world Study of Effectiveness and Safety in HR+/HER2- Breast Cancer Patients Treated With Ribociclib or Alpelisib — Completed
• A Study to Evaluate Real-world Brolucizumab Effectiveness and Safety in Japanese Patients With Neovascular Age-related Macular Degeneration (nAMD) — Completed
• Real-World Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia in Earlier Lines of Therapy — Completed
• Real-World Persistence and Adherence of Ofatumumab Compared to Self-Injectable and Oral DMTs in Patients With Multiple Sclerosis — Completed
• Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension — Running, not enrolling
• A Real-world Study to Assess the Characteristics and Long-term Effectiveness of Inclisiran in Chinese Adult Patients — Completed
• A Real-world Study to Assess the Use of Siponimod in Spain to Treat Patients With Secondary Progressive Multiple Sclerosis — Completed
• A Real-world Study of Inclisiran Adherence, Treatment Patterns, Patient Characteristics, and Effectiveness in ASCVD Patients With Hypercholesterolemia, ASCVD-risk Equivalent Patients With Hypercholesterolemia and Familial Hypercholesterolemia — Completed
• A Study to Assess COVID-19 Vaccination Immune Response in Multiple Sclerosis Patients Treated With Ofatumumab — Completed
• A Study to Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis — Completed
• Real-World HRU and Costs in DLBCL Pts With Tisa-cel and Axi-cel, a Medicare Study. — Completed